
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Distinct evolution and dynamics of epigenetic and genetic heterogeneity in acute myeloid leukemia
Sheng Li, Francine E. Garrett-Bakelman, Stephen S. Chung, et al.
Nature Medicine (2016) Vol. 22, Iss. 7, pp. 792-799
Open Access | Times Cited: 351
Sheng Li, Francine E. Garrett-Bakelman, Stephen S. Chung, et al.
Nature Medicine (2016) Vol. 22, Iss. 7, pp. 792-799
Open Access | Times Cited: 351
Showing 26-50 of 351 citing articles:
DNA methylation-calling tools for Oxford Nanopore sequencing: a survey and human epigenome-wide evaluation
Yang Liu, Wojciech Rosikiewicz, Ziwei Pan, et al.
Genome biology (2021) Vol. 22, Iss. 1
Open Access | Times Cited: 163
Yang Liu, Wojciech Rosikiewicz, Ziwei Pan, et al.
Genome biology (2021) Vol. 22, Iss. 1
Open Access | Times Cited: 163
Targeting enhancer switching overcomes non-genetic drug resistance in acute myeloid leukaemia
Charles C. Bell, Katie Fennell, Yih-Chih Chan, et al.
Nature Communications (2019) Vol. 10, Iss. 1
Open Access | Times Cited: 153
Charles C. Bell, Katie Fennell, Yih-Chih Chan, et al.
Nature Communications (2019) Vol. 10, Iss. 1
Open Access | Times Cited: 153
Principles and mechanisms of non-genetic resistance in cancer
Charles C. Bell, Omer Gilan
British Journal of Cancer (2019) Vol. 122, Iss. 4, pp. 465-472
Open Access | Times Cited: 151
Charles C. Bell, Omer Gilan
British Journal of Cancer (2019) Vol. 122, Iss. 4, pp. 465-472
Open Access | Times Cited: 151
Heterogeneity of the tumor immune microenvironment and its clinical relevance
Qingzhu Jia, Aoyun Wang, Yixiao Yuan, et al.
Experimental Hematology and Oncology (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 130
Qingzhu Jia, Aoyun Wang, Yixiao Yuan, et al.
Experimental Hematology and Oncology (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 130
Epigenetics, DNA damage, and aging
Carolina Soto-Palma, Laura J. Niedernhofer, Christopher Faulk, et al.
Journal of Clinical Investigation (2022) Vol. 132, Iss. 16
Open Access | Times Cited: 85
Carolina Soto-Palma, Laura J. Niedernhofer, Christopher Faulk, et al.
Journal of Clinical Investigation (2022) Vol. 132, Iss. 16
Open Access | Times Cited: 85
Comparative analysis of genome-scale, base-resolution DNA methylation profiles across 580 animal species
Johanna Klughammer, Daria Romanovskaia, Amelie Nemc, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 59
Johanna Klughammer, Daria Romanovskaia, Amelie Nemc, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 59
Epigenetic regulation in cancer therapy: From mechanisms to clinical advances
Lei Tao, Yue Zhou, Yuan Luo, et al.
MedComm – Oncology (2024) Vol. 3, Iss. 1
Open Access | Times Cited: 22
Lei Tao, Yue Zhou, Yuan Luo, et al.
MedComm – Oncology (2024) Vol. 3, Iss. 1
Open Access | Times Cited: 22
SHP-1 inhibition targets leukaemia stem cells to restore immunosurveillance and enhance chemosensitivity by metabolic reprogramming
Xi Xu, Yanhui Yu, Wendy Zhang, et al.
Nature Cell Biology (2024) Vol. 26, Iss. 3, pp. 464-477
Closed Access | Times Cited: 17
Xi Xu, Yanhui Yu, Wendy Zhang, et al.
Nature Cell Biology (2024) Vol. 26, Iss. 3, pp. 464-477
Closed Access | Times Cited: 17
Lactate controls cancer stemness and plasticity through epigenetic regulation
Nguyen T.B. Nguyen, Sira Gevers, Rutger N.U. Kok, et al.
Cell Metabolism (2025)
Open Access | Times Cited: 5
Nguyen T.B. Nguyen, Sira Gevers, Rutger N.U. Kok, et al.
Cell Metabolism (2025)
Open Access | Times Cited: 5
Cytarabine and daunorubicin for the treatment of acute myeloid leukemia
Tracy Murphy, Karen Yee
Expert Opinion on Pharmacotherapy (2017) Vol. 18, Iss. 16, pp. 1765-1780
Closed Access | Times Cited: 149
Tracy Murphy, Karen Yee
Expert Opinion on Pharmacotherapy (2017) Vol. 18, Iss. 16, pp. 1765-1780
Closed Access | Times Cited: 149
Loss of CHD1 Promotes Heterogeneous Mechanisms of Resistance to AR-Targeted Therapy via Chromatin Dysregulation
Zeda Zhang, Chuanli Zhou, Xiaoling Li, et al.
Cancer Cell (2020) Vol. 37, Iss. 4, pp. 584-598.e11
Open Access | Times Cited: 135
Zeda Zhang, Chuanli Zhou, Xiaoling Li, et al.
Cancer Cell (2020) Vol. 37, Iss. 4, pp. 584-598.e11
Open Access | Times Cited: 135
Non-Genetic Intra-Tumor Heterogeneity Is a Major Predictor of Phenotypic Heterogeneity and Ongoing Evolutionary Dynamics in Lung Tumors
Anchal Sharma, Elise Merritt, Xiaoju Hu, et al.
Cell Reports (2019) Vol. 29, Iss. 8, pp. 2164-2174.e5
Open Access | Times Cited: 118
Anchal Sharma, Elise Merritt, Xiaoju Hu, et al.
Cell Reports (2019) Vol. 29, Iss. 8, pp. 2164-2174.e5
Open Access | Times Cited: 118
Leukemic stem cells: identification and clinical application
Diana Hanekamp, Jacqueline Cloos, Gerrit Jan Schuurhuis
International Journal of Hematology (2017) Vol. 105, Iss. 5, pp. 549-557
Open Access | Times Cited: 115
Diana Hanekamp, Jacqueline Cloos, Gerrit Jan Schuurhuis
International Journal of Hematology (2017) Vol. 105, Iss. 5, pp. 549-557
Open Access | Times Cited: 115
The Impact of Heterogeneity on Single-Cell Sequencing
Samantha L. Goldman, Matthew MacKay, Ebrahim Afshinnekoo, et al.
Frontiers in Genetics (2019) Vol. 10
Open Access | Times Cited: 112
Samantha L. Goldman, Matthew MacKay, Ebrahim Afshinnekoo, et al.
Frontiers in Genetics (2019) Vol. 10
Open Access | Times Cited: 112
Clonal evolution in leukemia
Adolfo A. Ferrando, Carlos López-Otı́n
Nature Medicine (2017) Vol. 23, Iss. 10, pp. 1135-1145
Closed Access | Times Cited: 108
Adolfo A. Ferrando, Carlos López-Otı́n
Nature Medicine (2017) Vol. 23, Iss. 10, pp. 1135-1145
Closed Access | Times Cited: 108
Molecular and genetic alterations associated with therapy resistance and relapse of acute myeloid leukemia
Hubert Hackl, Ksenia Astanina, Rotraud Wieser
Journal of Hematology & Oncology (2017) Vol. 10, Iss. 1
Open Access | Times Cited: 105
Hubert Hackl, Ksenia Astanina, Rotraud Wieser
Journal of Hematology & Oncology (2017) Vol. 10, Iss. 1
Open Access | Times Cited: 105
MBD4 guards against methylation damage and germ line deficiency predisposes to clonal hematopoiesis and early-onset AML
Mathijs A. Sanders, Edward Chew, Christoffer Flensburg, et al.
Blood (2018) Vol. 132, Iss. 14, pp. 1526-1534
Open Access | Times Cited: 105
Mathijs A. Sanders, Edward Chew, Christoffer Flensburg, et al.
Blood (2018) Vol. 132, Iss. 14, pp. 1526-1534
Open Access | Times Cited: 105
Characterization of cancer genomic heterogeneity by next-generation sequencing advances precision medicine in cancer treatment
Jialing Zhang, Stephan S. Späth, Sadie L. Marjani, et al.
Precision Clinical Medicine (2018) Vol. 1, Iss. 1, pp. 29-48
Open Access | Times Cited: 104
Jialing Zhang, Stephan S. Späth, Sadie L. Marjani, et al.
Precision Clinical Medicine (2018) Vol. 1, Iss. 1, pp. 29-48
Open Access | Times Cited: 104
Bone marrow evaluation for diagnosis and monitoring of acute myeloid leukemia
Mary‐Elizabeth M. Percival, Catherine Lai, Elihu H. Estey, et al.
Blood Reviews (2017) Vol. 31, Iss. 4, pp. 185-192
Open Access | Times Cited: 98
Mary‐Elizabeth M. Percival, Catherine Lai, Elihu H. Estey, et al.
Blood Reviews (2017) Vol. 31, Iss. 4, pp. 185-192
Open Access | Times Cited: 98
Clonal evolution of acute myeloid leukemia from diagnosis to relapse
Sebastian Vosberg, Philipp A. Greif
Genes Chromosomes and Cancer (2019) Vol. 58, Iss. 12, pp. 839-849
Open Access | Times Cited: 93
Sebastian Vosberg, Philipp A. Greif
Genes Chromosomes and Cancer (2019) Vol. 58, Iss. 12, pp. 839-849
Open Access | Times Cited: 93
Aberrant DNA Methylation in Acute Myeloid Leukemia and Its Clinical Implications
Xian‐Wen Yang, Molly Pui Man Wong, Ray Kit Ng
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 18, pp. 4576-4576
Open Access | Times Cited: 85
Xian‐Wen Yang, Molly Pui Man Wong, Ray Kit Ng
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 18, pp. 4576-4576
Open Access | Times Cited: 85
Atypical acute myeloid leukemia-specific transcripts generate shared and immunogenic MHC class-I-associated epitopes
Grégory Ehx, Jean‐David Larouche, Chantal Durette, et al.
Immunity (2021) Vol. 54, Iss. 4, pp. 737-752.e10
Open Access | Times Cited: 82
Grégory Ehx, Jean‐David Larouche, Chantal Durette, et al.
Immunity (2021) Vol. 54, Iss. 4, pp. 737-752.e10
Open Access | Times Cited: 82
Translating insights into tumor evolution to clinical practice: promises and challenges
Matthew W. Fittall, Peter Van Loo
Genome Medicine (2019) Vol. 11, Iss. 1
Open Access | Times Cited: 77
Matthew W. Fittall, Peter Van Loo
Genome Medicine (2019) Vol. 11, Iss. 1
Open Access | Times Cited: 77
Silencing of LINE-1 retrotransposons is a selective dependency of myeloid leukemia
Zhimin Gu, Yuxuan Liu, Yuannyu Zhang, et al.
Nature Genetics (2021) Vol. 53, Iss. 5, pp. 672-682
Open Access | Times Cited: 76
Zhimin Gu, Yuxuan Liu, Yuannyu Zhang, et al.
Nature Genetics (2021) Vol. 53, Iss. 5, pp. 672-682
Open Access | Times Cited: 76
Single cell RNA sequencing of AML initiating cells reveals RNA-based evolution during disease progression
Lindsay Stetson, Dheepa Balasubramanian, Susan Pereira Ribeiro, et al.
Leukemia (2021) Vol. 35, Iss. 10, pp. 2799-2812
Open Access | Times Cited: 66
Lindsay Stetson, Dheepa Balasubramanian, Susan Pereira Ribeiro, et al.
Leukemia (2021) Vol. 35, Iss. 10, pp. 2799-2812
Open Access | Times Cited: 66